SCS - AMPAlive - Ingredients, Usage, Label
AMPAlive
Kickstart Your Master Metabolic Switch
Your weight is controlled by a master enzyme that declines with age. This revolutionary product activates this enzyme and reboots your body to start burning calories the way it did when you were young… instead storing them!
Product Information
AMPAlive is recommended for:
- Healthy Weight Loss
- Heightened Energy
- Blood Sugar Management
- Cellular wellbeing
- AMPK determines whether our cells are programmed to store fat or burn it.
- AMPAlive uses the principle of shifting your cells from anabolism to catabolism to achieve weight loss.
- Catabolism breaks down compounds to release energy, anabolism is the opposite… it stores it for future use
There are 3 AMPK Blockers:
a. Overeating
b. Inflammation
c. Aging
We practice Truth-In-Labeling:
Everything you see on the label is exactly what is in the supplement. We believe that the consumer has the right to know what is in his or her food. We guarantee our product 100%.
Label:
Each bottle contains 56 vegetarian capsules /28 servings
Usage: Healthy adults over the age of 18 can take 1 capsule twice daily. Preferably with food.
If you have a medical condition, take medications, or are pregnant/nursing you should always check with your physician to make sure a supplement is 100% safe for you.
*See the P450 Drug precaution listed on the label of this product.
P450 Drug Precaution: The precaution listed on the AMPAlive label, relates specifically to the ingredient Berberine. Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates) interact with BERBERINE.
Some medications are changed and broken down by the liver. Berberine might decrease how quickly the liver breaks down some medications. Taking berberine along with some medications that are broken down by the liver can increase the effects and side effects of some medications.
Some medications changed by the liver include cyclosporin (Neoral, Sandimmune), lovastatin (Mevacor), clarithromycin (Biaxin), indinavir (Crixivan), sildenafil (Viagra), triazolam (Halcion), and many others.
Before taking berberine, talk to your healthcare provider if you are taking any medications that are changed by the liver.
AMPAlive is non-GMO, vegan, vegetarian and free of dairy, soy, and gluten.
AmpaLive is manufactured in a cGMP/FDA compliant facility. We insist on, and only work with, manufacturers who follow strict processes and complete thorough testing to ensure our products are safe, high quality and made to the highest industry standards.
About The Formula:
Chromax, Chromium Picolinate:
- Destroys food cravings so you don’t overeat which can directly affect your waistline.
Gymnema Sylvestre:
- Gymnema sylvestre is regarded as one of the plants with potent anti diabetic properties.
Berberine HCL:
- A plant alkaloid that has been used for thousands of years in traditional Chinese and Ayurvedic medicine to provide antioxidant activity, immune system support and proper microbial balance. Its relationship to cardiovascular support has been of high importance in recent years due to its ability to support normal homocysteine levels and cholesterol within normal ranges.
Is this product tested for purity? Yes, it's been formulated & manufactured in the USA in a GMP/FDA compliant facility. We insist on, and only work with, manufacturers who follow strict processes and complete thorough testing to ensure our products are safe, high quality and made to the highest industry standards.
To learn more or place an order go here: https://youryouthmetabolism.com
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
References:
(1) The Health Effects of Overweight and Obesity | Healthy Weight | CDC. (n.d.). Retrieved from https://www.cdc.gov/healthyweight/effects/index.html
(2) DeSilver, D. (2016, December 13). How America's diet has changed over time. Retrieved from http://www.pewresearch.org/fact-tank/2016/12/13/whats-on-your-table-how-americas-diet-has-changed-over-the-decades/
(3) Sim, A. Y., Wallman, K. E., Fairchild, T. J., & Guelfi, K. J. (2014, March). High-intensity intermittent exercise attenuates ad-libitum energy intake. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23835594
(4) Pomerleau, M., Imbeault, P., Parker, T., & Doucet, E. (2004, November). Effects of exercise intensity on food intake and appetite in women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15531670
(5) Gibala, M. J., McGee, S. L., Garnham, A. P., Howlett, K. F., Snow, R. J., & Hargreaves, M. (2009, March). Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1alpha in human skeletal muscle. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19112161
(6) Sim, A. Y., Wallman, K. E., Fairchild, T. J., & Guelfi, K. J. (2014, March). High-intensity intermittent exercise attenuates ad-libitum energy intake. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23835594
(7) Cantó, C., & Auwerx, J. (2011, August). Calorie restriction: Is AMPK a key sensor and effector? Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627048/
(8) Heilbronn, L. K., De Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., . . . Pennington CALERIE Team. (2006, April 05). Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692623/
(9) Mattison, J. A., Colman, R. J., Beasley, T. M., Allison, D. B., Kemnitz, J. W., Roth, G. S., . . . Anderson, R. M. (2017, January 17). Caloric restriction improves health and survival of rhesus monkeys. Retrieved from https://www.nature.com/articles/ncomms14063
(10) Pérez-Rubio, K. G., González-Ortiz, M., Martínez-Abundis, E., Robles-Cervantes, J. A., & Espinel-Bermúdez, M. C. (2013, October). Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2380899
(11) Doggrell, S. A. (2005, May). Berberine--a novel approach to cholesterol lowering. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15926873
(12) Pirillo, A., & Catapano, A. L. (2015, December). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26520899
(13) Hu, Y., Ehli, E. A., Kittelsrud, J., Ronan, P. J., Munger, K., Downey, T., . . . Davies, G. E. (2012, July 15). Lipid-lowering effect of berberine in human subjects and rats. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22739410
(14) Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., Xu, L., & Li, M. (2012). Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22474499
(15) Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect of carbohydrate craving. J Psychiatr Pract. 2005; 11(5):302-314. (Pg. 310)
(16) Chromium from Chromax, chromium picolinate (1000 mcg for 8 weeks in overweight and obese women), as compared to placebo, reduced food intake 25% vs 8% (p < 0.0001), hunger levels (p < 0.05), and fat cravings (p < 0.0001).
(17) Jang, J., Jung, Y., Seo, S. J., Kim, S., Shim, Y. J., Cho, S. H., . . . Yoon, Y. (2017, June). Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436149/
(18) Dr. Jacob Schor, "Clinical Applications for Berberine: Potential therapeutic applications in metabolic Disorder, type 2 diabetes, and dyslipidemia", Natural Medicine Journal 4 (2012)
(19) Yun Lee et. al., "Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic", Diabetes 55 (2006).
(20) Hu, Y., Ehli, E. A., Kittelsrud, J., Ronan, P. J., Munger, K., Downey, T., . . . Davies, G. E. (2012). Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine,19(10), 861-867. doi:10.1016/j.phymed.2012.05.009
(21) Dong, H., Wang, N., Zhao, L., & Lu, F. (2012). Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine,2012, 1-12. doi:10.1155/2012/591654
(22) Hu, Y., Ehli, E. A., Kittelsrud, J., Ronan, P. J., Munger, K., Downey, T., . . . Davies, G. E. (2012). Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine,19(10), 861-867. doi:10.1016/j.phymed.2012.05.009
(23) McCarty MF. AMPK activation—protean potential for boosting healthspan. Age. 2014;36(2):641-663. doi:10.1007/s11357-013-9595-y.
(24) Wu, X., MD, Xu, X., MS, Shen, J., MD, Perricone, N. V., & Preuss, H. G. (2010). Enhanced Weight Loss From a Dietary Supplement Containing Standardized Phaseolus vulgaris Extract in Overweight Men and Women. The Journal of Applied Research, 10(2).
(25) Barrett, M. L., & Udani, J. K. (2011, March 17). A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071778/
(26) Anton, S. D., Morrison, C. D., Cefalu, W. T., Martin, C. K., Coulon, S., Geiselman, P., . . . Williamson, D. A. (2008, October). Effects of chromium picolinate on food intake and satiety. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18715218
(27) Chromium from Chromax, chromium picolinate (1000 mcg for 8 weeks in overweight and obese women), as compared to placebo, reduced food intake 25% vs 8% (p < 0.0001), hunger levels (p < 0.05), and fat cravings (p < 0.0001).
(28) A Double-Blind, Placebo-Controlled, Exploratory Trial of... : Journal of Psychiatric Practice®. (n.d.). Retrieved from https://journals.lww.com/practicalpsychiatry/Abstract/2005/09000/A_Double_Blind,_Placebo_Controlled,_Exploratory.4.aspx
(29) (n.d.). Retrieved from http://ergo-log.com/gymnema-sylvestre.html
(30) Ishaque, S., Shamseer, L., Bukutu, C., & Vohra, S. (2012, May 29). Rhodiola rosea for physical and mental fatigue: A systematic review. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541197/
(31) Lishmanov, I. B., Trifonova, Z. V., Tsibin, A. N., Maslova, L. V., & Dement'eva, L. A. (1987, April). Plasma beta-endorphin and stress hormones in stress and adaptation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2952180
(32) Hewagalamulage, S. D., Lee, T. K., Clarke, I. J., & Henry, B. A. (2016, July). Stress, cortisol, and obesity: A role for cortisol responsiveness in identifying individuals prone to obesity. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27345309
(33) Pomari, E., Stefanon, B., & Colitti, M. (2015, May 11). Effects of Two Different Rhodiola rosea Extracts on Primary Human Visceral Adipocytes. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25970041
(34) Verpeut, J. L., Walters, A. L., & Bello, N. T. (2013, June). Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808124
(35) McCarty MF. AMPK activation—protean potential for boosting healthspan. Age. 2014;36(2):641-663. doi:10.1007/s11357-013-9595-y.
(36) Herzig, S., & Shaw, R. J. (2017, October 04). AMPK: Guardian of metabolism and mitochondrial homeostasis. Retrieved from https://www.nature.com/articles/nrm.2017.95
(37) Genetics, lifestyle and longevity: Lessons from centenarians. (2015, February 04). Retrieved from https://www.sciencedirect.com/science/article/pii/S2212066115000022